
Biopharma companies don’t usually buy experimental drugs that don’t work.
But that’s exactly what CODA Biotherapeutics has done.
Biopharma companies don’t usually buy experimental drugs that don’t work.
But that’s exactly what CODA Biotherapeutics has done.